Greenwich LifeSciences
(NASDAQ) GLSI
Greenwich LifeSciences Financials at a Glance
Market Cap
$370.05M
Revenue (TTM)
$0.00
Net Income (TTM)
$19.48M
EPS (TTM)
$-1.46
P/E Ratio
-18.24
Dividend
$0.00
Beta (Volatility)
1.33 (Average)
Dividend
$0.00
Beta (Volatility)
1.33 (Average)
Price
$25.97
Volume
6,523
Open
$26.15
Price
$25.97
Volume
6,523
Open
$26.15
Previous Close
$25.97
Daily Range
$24.69 - $26.36
52-Week Range
$7.78 - $34.10
Dividend
$0.00
Beta (Volatility)
1.33 (Average)
Price
$25.97
Volume
6,523
Open
$26.15
Previous Close
$25.97
Daily Range
$24.69 - $26.36
52-Week Range
$7.78 - $34.10
GLSI News
GLSI: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Greenwich LifeSciences
Industry
Biotechnology
Sector
Health CareEmployees
8
CEO
Snehal S. Patel, MBA
Headquarters
Stafford, TX 77477, US
GLSI Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-543%
Return on Capital
-9%
Return on Assets
-5%
Earnings Yield
-5.48%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$370.05M
Shares Outstanding
13.85M
Volume
6.52K
Short Interest
0.00%
Avg. Volume
506.05K
Financials (TTM)
Gross Profit
$3.61K
Operating Income
$16.01M
EBITDA
$15.79M
Operating Cash Flow
$7.27M
Capital Expenditure
$3.00
Free Cash Flow
$7.27M
Cash & ST Invst.
$4.09M
Total Debt
$0.00
Greenwich LifeSciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
$370.05M
N/A
Market Cap/Employee
$92.51M
N/A
Employees
4
N/A
Net Income
$4.15M
-55.6%
EBITDA
$4.15M
-52.2%
Quarterly Fundamentals
Net Cash
$3.81M
-34.6%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-5.12%
N/A
Return on Invested Capital
-8.96%
N/A
Free Cash Flow
$2.67M
-3.4%
Operating Cash Flow
$2.67M
-3.4%